Insights On Trial Design
-
Strategic CMC Considerations For Pre-IND Meetings: Setting The Stage For A Successful TPP
9/1/2025
In biotechnology, the Pre-Investigational New Drug (Pre-IND) stage is a critical juncture. Explore the pivotal role of Chemistry, Manufacturing, and Controls (CMC) in navigating this phase.
-
Shifting Policies Can Spark Progress In Clinical Trial Diversity
2/13/2025
Learn how shifting policies create opportunities for the private sector to prioritize innovation in clinical trials for better healthcare.
-
 Life Sciences Meetings Need More Than Logistics
8/6/2026
Life sciences meetings often extend beyond investigators’ meetings. Strong planning helps teams support clinical, commercial, governance, and internal programs without adding pressure to the host team.
-
Operationalizing Immuno-Oncology Studies
5/29/2026
Managing CRS and immune risks demands early detection, rapid response, and skilled teams. Strong infrastructure and clear protocols enable safer immunotherapy trials beyond academic centers.
-
Protocol Design Choices That Trigger IRB And Regulatory Requirements
8/20/2026
Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.
-
Can Your RTSM Software Vendor Handle Your Clinical Trial's Timeline Slip?
3/25/2026
This clip examines why shifting study timelines expose weaknesses in rigid RTSM systems and highlights how flexible technology helps trials stay on track when plans inevitably change.
-
Building Recruitment Into Early-Phase Trial Design
7/30/2026
Successful recruitment starts with smart study design. Early recruitment insight improves feasibility, supports realistic timelines, and reduces enrollment risk.
-
Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs
2/20/2025
Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
-
Pioneering Clinical Research For Native American Communities In South Dakota
1/31/2025
Lynn Bartholow is transforming clinical research for Native American populations. Explore her journey into clinical research and efforts to build trust and foster participation and community engagement.
-
Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions
5/8/2026
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.